EMAIL DETAILS

Confidentiality Notice: This electronic message and any attachment(s) are confidential and may be subject to the attorney/client privilege and/or work product immunity. This e-mail is only for the use of the intended recipient(s). If you have received this e-mail in error, please notify the sender immediately by replying to this e-mail, then delete this message and any attachment(s) from your system. Any unintended transmission expressly shall not waive the attorney/client privilege or any other privilege.

Begin forwarded message:

> From: "Yung,W K Alfred" <wyung@mdanderson.org>
> Date: May 14, 2014 at 7:29:21 PM EDT
> To: 'Hallie' <halliebiden@gmail.com>
> Cc: Beau Biden <261penn@gmail.com>, "Downey,Ginger" <GDowney@mdanderson.org>, "Lee,Evalu T" <etlee@mdanderson.org>
> Subject: RE: Mood Assessment Template
>
> Jon sent some pictures to me. They looks very good. I am pleased to see good level of response in contrast enhancement and flair. But I like to see more shrinkage of the nodule. I talked to Jon just now, I want to increase the dose of Avastin to 7.5 mg/Kg. He is checking on the order and if they need to get re-authorization.
> Al
>
> W.K. Alfred Yung, M.D.
> Chairman, Department of Neuro-Oncology
> Margaret and Ben Love Chair in Clinical Cancer Care
> UT M. D. Anderson Cancer Center, Unit 431
> 1515 Holcombe Blvd
> Houston, TX 77030
> Tele: 713-794-1285
> Fax: 713-563-0151
> wyung@mdanderson.org
>
> From: Hallie [mailto:halliebiden@gmail.com]
> Sent: Wednesday, May 14, 2014 3:38 PM
> To: Yung,W K Alfred
> Cc: Beau Biden; Downey,Ginger; Lee,Evalu T
> Subject: Re: Mood Assessment Template
>
> Ok, we will fill out and email it back to you tomorrow. Were you able to see/ get the MRI scan pictures from Dr Glass today?
>
> Hallie Olivere Biden
> 302-540-3774
>
>
> On May 14, 2014, at 4:17 PM, "Yung,W K Alfred" <wyung@mdanderson.org> wrote:
>
> Beau and Hallie,
> As I mentioned during you last visit here that I have applied to the drug company Novartis for special permission (single patient IND) to give you the new drug BKM-120. I went ahead to get this permission in case I want to use it after the June scan. The company has given us the approval. One condition for this approval is for Beau to fill out the attached mood assessment form. This is required by the FDA since the drug has a potential to affect the mood, so they want to have a base line.
> Please fill this out, a very simple form, and send it back to us, then we will have completed all the paperwork for this application.
> Al
>
> W.K. Alfred Yung, M.D.
> Chairman, Department of Neuro-Oncology
> Margaret and Ben Love Chair in Clinical Cancer Care
> UT M. D. Anderson Cancer Center, Unit 431
> 1515 Holcombe Blvd
> Houston, TX 77030
> Tele: 713-794-1285
> Fax: 713-563-0151
> wyung@mdanderson.org
>
> From: Downey,Ginger
> Sent: Tuesday, May 13, 2014 8:44 AM
> To: Yung,W K Alfred
> Subject: Mood Assessment Template
> Importance: High
>
>
>
> Ginger Downey
> Executive Assistant to
> W.K. Alfred Yung, M.D., Professor and Chair
> Department of Neuro-Oncology
> gdowney@mdanderson.org|713.745.3751 Direct | 713.563.0151 FAX
>
> <image001.png>
>
> C A R I N G • I N T E G R I T Y • D I S C O V E R Y
> 1515 HOLCOMBE BOULEVARD • HOUSTON, TEXAS 77030-4009
> A Comprehensive Cancer Center designated by the National Cancer Institute located in the Texas Medical Center
>
>
> <mood assessment.docx